Correlation Between Intercept Pharmaceuticals and Verastem

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Intercept Pharmaceuticals and Verastem at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Intercept Pharmaceuticals and Verastem into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Intercept Pharmaceuticals and Verastem, you can compare the effects of market volatilities on Intercept Pharmaceuticals and Verastem and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Intercept Pharmaceuticals with a short position of Verastem. Check out your portfolio center. Please also check ongoing floating volatility patterns of Intercept Pharmaceuticals and Verastem.

Diversification Opportunities for Intercept Pharmaceuticals and Verastem

-0.66
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Intercept and Verastem is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Intercept Pharmaceuticals and Verastem in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verastem and Intercept Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Intercept Pharmaceuticals are associated (or correlated) with Verastem. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verastem has no effect on the direction of Intercept Pharmaceuticals i.e., Intercept Pharmaceuticals and Verastem go up and down completely randomly.

Pair Corralation between Intercept Pharmaceuticals and Verastem

If you would invest  299.00  in Verastem on August 30, 2024 and sell it today you would earn a total of  158.00  from holding Verastem or generate 52.84% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy2.27%
ValuesDaily Returns

Intercept Pharmaceuticals  vs.  Verastem

 Performance 
       Timeline  
Intercept Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Intercept Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Intercept Pharmaceuticals is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Verastem 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Verastem are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Verastem displayed solid returns over the last few months and may actually be approaching a breakup point.

Intercept Pharmaceuticals and Verastem Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Intercept Pharmaceuticals and Verastem

The main advantage of trading using opposite Intercept Pharmaceuticals and Verastem positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Intercept Pharmaceuticals position performs unexpectedly, Verastem can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verastem will offset losses from the drop in Verastem's long position.
The idea behind Intercept Pharmaceuticals and Verastem pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Commodity Directory
Find actively traded commodities issued by global exchanges